Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3 - Wikidata - wikimedia - TriplyDB

Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3

Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3

http://www.wikidata.org/entity/Q34729815

about

Methylsulfonylmethane Inhibits RANKL-Induced Osteoclastogenesis in BMMs by Suppressing NF-κB and STAT3 Activities Odontoclastogenesis of mouse papilla-derived MDPC-23 cells induced by lipopolysaccharide.Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway Lipopolysaccharide (LPS)-Induced Autophagy Is Responsible for Enhanced Osteoclastogenesis.Escin induces caspase-dependent apoptosis and autophagy through the ROS/p38 MAPK signalling pathway in human osteosarcoma cells in vitro and in vivo.Involvement of serum-derived exosomes of elderly patients with bone loss in failure of bone remodeling via alteration of exosomal bone-related proteins.

P2860

Q28552847-07F1A020-9085-4DD1-A062-97C1850D4735 Q36319455-53913E22-9CAB-4FF3-9B5E-6CF15F818AFA Q36775054-789CF468-E0DE-443F-9D55-DA8B403B9723 Q46260170-4953E148-4E77-4830-BDC4-824A866ACC5E Q46288383-AE3E5798-ED00-4956-99BE-A99FF4A61CFD Q51758043-FBA8B501-E3EA-4E31-B750-ED71D26D690D

P2860

Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3

http://www.wikidata.org/entity/Q34729815

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@ast

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@en

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@nl

type

label

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@ast

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@en

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@nl

prefLabel

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@ast

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@en

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@nl

P1433

Q34729815-D053EC2B-DB4F-4C2B-8328-C5DAD2202772

P1476

Q34729815-EEE9F8B2-3933-49C7-9EB8-74DF8877B648

P2093

Q34729815-36065C24-BF2C-42D5-937E-FB345CC01101

Q34729815-622364AA-1515-4825-8DC4-8A6E9A64D7DC

Q34729815-8387C1FD-0652-4F74-9FB5-EA686123952D

Q34729815-9636D0AE-7C11-44D6-95CB-721FB1E662F1

Q34729815-F605F117-35C8-45CC-90A7-4B66BB2948B7

P2860

Q34729815-01FF102D-944B-40E2-84AF-3245E5E3724C

Q34729815-0330FAEE-95D1-4DB8-BC34-7514CAEB93FE

Q34729815-038648C9-C68A-4487-8E48-F7CE05DFB7A5

Q34729815-03A7E7C2-D7A2-488C-AEA7-5127CBA87AEF

Q34729815-04B21B2F-9730-4A50-97C3-DB01C3BF57F2

Q34729815-0BFC3BD0-81E5-449E-AE9C-4311590CCF6B

Q34729815-1283B76E-B571-409F-AF00-508FCA19DB0F

Q34729815-16E59DD8-D867-4AF4-941D-C8EC5A85598F

Q34729815-1FB082BD-540A-47D0-AD07-3B9B97896318

Q34729815-2131CBD8-696D-48BD-8DBA-E0E22A4E1A41

P304

Q34729815-8DD0C3B2-CD19-461B-93DA-CA4892AF8E28

P31

Q34729815-5010BD04-AA57-455F-82A9-4A78569A27E3

P356

Q34729815-9C1F73CE-2EAC-4049-A651-27E412F59DE4

P433

Q34729815-601645F2-95D8-407F-8D22-9FE80A4A0360

P478

Q34729815-25E17A98-EDD6-41BC-BC42-952CD2A0D664

P50

Q34729815-A931F681-4B7E-4EC2-AB91-6B1122C9FE1D

P577

Q34729815-DDE85B15-E8AA-41B0-BD7F-BB5B08198687

P698

Q34729815-E9216008-49FA-4A09-86A4-1FE7CF5780B9

P921

Q34729815-3DAE5939-9690-4867-8070-AF929FDD2587

P932

Q34729815-DCFB2046-6CB2-46FC-BF26-912AF175DB2D

P356

P1433

Antioxidants & Redox Signaling

P1476

Peroxiredoxin II negatively re ...... nd bone loss via JNK and STAT3

@en

P2093

A Long Sae Mi Noh

http://www.w3.org/2001/XMLSchema#string

Hyojung Park

http://www.w3.org/2001/XMLSchema#string

Ju-Hee Kang

http://www.w3.org/2001/XMLSchema#string

Jung-Sun Sim

http://www.w3.org/2001/XMLSchema#string

Mijung Yim

http://www.w3.org/2001/XMLSchema#string

P2860

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

Thioredoxin-dependent peroxide reductase from yeast.

Structure, mechanism and regulation of peroxiredoxins

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway

Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling

T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene

Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock

Osteoclast differentiation and activation

P304

63-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/ARS.2013.5748

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25074339

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

4270137

http://www.w3.org/2001/XMLSchema#string